The novel treatment of this peptide represents a exciting development in the management of type 2 diabetes. Different to existing therapies, tirzepatide affects multiple pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide691077.fitnell.com/83135895/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment